Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

822 trials with published results (23%)

Research Maturity

2654 completed trials (73% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.5%

201 terminated out of 3653 trials

Success Rate

93.0%

+6.4% vs benchmark

Late-Stage Pipeline

23%

842 trials in Phase 3/4

Results Transparency

31%

822 of 2654 completed with results

Key Signals

822 with results93% success201 terminated

Data Visualizations

Phase Distribution

2,683Total
Not Applicable (958)
Early P 1 (24)
P 1 (340)
P 2 (519)
P 3 (479)
P 4 (363)

Trial Status

Completed2,654
Unknown324
Terminated201
Recruiting194
Withdrawn118
Active Not Recruiting79

Trial Success Rate

93.0%

Benchmark: 86.5%

Based on 2654 completed trials

Clinical Trials (3653)

Showing 20 of 20 trials
NCT05274425Active Not RecruitingPrimary

A 24-week rPMS Study in Real-world Setting for Enerzair

NCT07666490Phase 4RecruitingPrimary

BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])

NCT02351141Not ApplicableRecruitingPrimary

Structure and Function MRI of Asthma

NCT07394127Not ApplicableCompleted

A Community-Based Swimming and Inspiratory Muscle Training Intervention to Promote Physical Activity and Asthma Control in Children With Mild Asthma

NCT01678222Completed

The COX-2 Gene and the Immune System

NCT07712393Phase 1RecruitingPrimary

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

NCT07301255Phase 2RecruitingPrimary

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

NCT07664527Phase 4Not Yet RecruitingPrimary

Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate

NCT06825871Not ApplicableCompletedPrimary

Automated Inhaler Monitoring for Asthma Medication Usage

NCT07733635Not Yet Recruiting

Vitamin D Status and Asthma Control, Pulmonary Function, and Oxidative Stress in Adults With Bronchial Asthma

NCT00341237Recruiting

Personalized Environment and Genes Study

NCT03937804CompletedPrimary

New Approaches for Empowering Studies of Asthma in Populations of African Descent

NCT03953300Phase 4Active Not RecruitingPrimary

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

NCT05776927Phase 3Not Yet RecruitingPrimary

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

NCT03927820Not ApplicableCompleted

A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)

NCT07219173Phase 2RecruitingPrimary

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

NCT05059210Not ApplicableActive Not RecruitingPrimary

Primary Care Implementation and Evaluation of Coach McLungs

NCT07728578Not ApplicableNot Yet RecruitingPrimary

Effect of Pilates Training Versus High Intensity Interval Training on Cardiorespiratory Fitness in Asthmatic Patients

NCT07556159RecruitingPrimary

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

NCT07228052Phase 4RecruitingPrimary

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department

Scroll to load more

Research Network

Activity Timeline